This brand name is authorized in Japan
The drug BARIBRIGHT contains one active pharmaceutical ingredient (API):
|
1
Barium sulfate
UNII 25BB7EKE2E - BARIUM SULFATE
|
|
Barium sulfate is inert and has no pharmacological action. It serves only as a radiopaque substance to opacify the gastro-intestinal tract during X-ray examinations. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V08BA | Barium sulfate containing X-ray contrast media | V Various → V08 Contrast media → V08B X-ray contrast media, non-iodinated |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 7212020B1033, 7212032B1028, 7212034B1027 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
